J. L. Liu Yin

发表

Comparison of ‘sequential’ versus ‘standard’ chemotherapy as re‐induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML‐R trial

A. Burnett, K. Wheatley, J. A. Liu Yin, 2001, British journal of haematology.

Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia—a randomized, placebo-controlled, double-blind safety and efficacy study

A. Ganser, L. Kanz, J. Szer, 2003, Annals of Hematology.

Eosinophilic fasciitis and aplastic anaemia.

M. Narayanan, A. Freemont, P. Holt, 1988, Clinical and laboratory haematology.

Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance

K. Tobal, J. A. Liu Yin, J. L. Liu Yin, 1999, British journal of haematology.

Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia

K. Tobal, M. Garg, J. A. Liu Yin, 2003, British journal of haematology.

Therapy‐related acute promyelocytic leukaemia

J. A. Liu Yin, G. Lucas, M. Bhavnani, 1994, British journal of haematology.

Minimal residual disease in acute myeloid leukaemia.

J. A. Liu Yin, J. L. Liu Yin, 2002, Best practice & research. Clinical haematology.

Prognostic significance of FLT3 ITD and D835 mutations in AML patients.

A. Awan, K. Tobal, M. Sheikhha, 2003, The hematology journal : the official journal of the European Haematology Association.

P‐glycoprotein and multidrug resistance‐associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells

R. Scheper, L. Green, J. A. Liu Yin, 2000, British journal of haematology.

Overexpression of lung‐resistance protein and increased P‐glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival

R. Scheper, L. Green, J. A. Liu Yin, 1998, British journal of haematology.

Megakaryopoiesis in vitro in myelodysplastic syndromor and development es and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors

M. Brereton, J. A. Liu Yin, J. Adams, 2000 .

The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia

M. Brereton, J. A. Liu Yin, Julie Adams, 1999, British journal of haematology.

The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia

M. Brereton, K. Hyde, J. A. Liu Yin, 1997, British journal of haematology.

ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT

J. A. Liu Yin, P. Johnson, J. L. Liu Yin, 1993, British journal of haematology.

Effect of gemtuzumab ozogamicin on acute myeloid leukaemia blast cells in vitro, as a single agent and combined with other cytotoxic agents

K. Morris, J. A. Liu Yin, J. Adams, 2006, British journal of haematology.

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced‐intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

J. Burthem, C. Craddock, E. Tholouli, 2008, British journal of haematology.

THE CLINICAL USEFULNESS OF C‐REACTIVE PROTEIN MEASUREMENTS

D. Gozzard, J. A. Liu Yin, I. Delamore, 1986, British journal of haematology.

Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors.

M. Brereton, J. Adams, B. Harrison, 2000, British journal of haematology.

Evaluation of cytogenetic conversion to Ph− haemopoiesis in long‐term bone marrow culture for patients with chronic myeloid leukaemia on conventional hydroxyurea therapy, on pulse high‐dose hydroxyurea and on interferon‐alpha

W. Ryder, J. Chang, T. Dexter, 1996, British journal of haematology.

Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR.

K. Tobal, J. A. Liu Yin, J. L. Liu Yin, 1998, Leukemia & lymphoma.

Expression of AML1/MTG8 transcripts in clonogenic cells grown from bone marrow of patients in remission of acute myeloid leukaemia with t(8;21)

M. Brereton, K. Tobal, Julie Adams, 1997, British Journal of Haematology.

Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phase.

K. Tobal, S. Keeney, M. Saunders, 1996, Leukemia.

INTENSIVE INDUCTION CHEMOTHERAPY IN ELDERLY PATIENTS

J. Reiffers, P. Hurteloup, A. Stoppa, 1992 .

Portal hypertension and ascites in systemic mastocytosis.

J. A. Liu Yin, S. Azzawi, W. Turck, 1989, Postgraduate medical journal.

Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin.

K. Morris, Julie Adams, J. L. Liu Yin, 2009, Leukemia research.

High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome.

K. Tobal, M. Sheikhha, J. A. Liu Yin, 2002, British journal of haematology.

THE ROLE OF GRANULOCYTE‐ AND GRANULOCYTE‐MACROPHAGE‐COLONY‐STIMULATING FACTORS IN THE TREATMENT OF ACUTE MYELOID LEUKAEMIA

J. A. Liu Yin, Peter R. E. Johnson, P. Johnson, 1997, British journal of haematology.

Invasive aspergillosis: clusters and sources?

J. A. Liu Yin, G. Lucas, K. Loudon, 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

A. Ganser, G. Papa, J. Szer, 1997 .

A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group.

A. Ganser, G. Papa, J. Szer, 1997, Blood.